Empagliflozin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5159 publications
Nephrology: What You May Have Missed in 2025.
Journal: Annals of internal medicine
Published: April 13, 2026
Empagliflozin preserves cardiac function and modulates metabolism in a mouse model of Duchenne muscular dystrophy.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 27, 2026
Letter to the Editor: Indication-Specific Cost-Effectiveness of Empagliflozin Versus Dapagliflozin: Implications for Clinical and Policy Decision-Making.
Journal: Hospital pharmacy
Published: March 12, 2026
Aldosterone synthase inhibitors in hypertension and chronic kidney disease: double the benefit?
Journal: Current opinion in nephrology and hypertension
Published: March 12, 2026
Effect of SGLT2 Inhibitors on Atrial Electromechanical Delay in Patients with Type 2 Diabetes.
Journal: Angiology
Published: March 12, 2026
Helicobacter pylori Eradication Therapy-induced Severe Hypoglycemia in a Hemodialysis Patient with Type 2 Diabetes Mellitus.
Journal: Internal medicine (Tokyo, Japan)
Published: March 11, 2026
A rare case of incidental asymptomatic emphysematous cystitis in a patient taking empagliflozin.
Journal: Urology case reports
Published: February 28, 2026
Corrigendum "Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway" [Biomed. Pharmacother. 178 (2024), 117278].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 26, 2026
Last Updated: 04/28/2026